alcohol and glp-1 GLP‐1 Receptor Agonists for Treating Use Disorder: A Critical Review - Woo - 2026 - Alcohol, Clinical Experimental Research GLP-1 shifts alcohol market dynamics
Description
DOI: 10.1001/jamapsychiatry.2024.3599
Third-party testing provides accountability that self-certification alone cannot offer
Unregulated compounded GLP-1 products carry serious safety concerns because they are not reviewed or approved by the FDA for safety, effectiveness, or quality
If you are considering compounded medications, its important to discuss the risks and benefits with a licensed healthcare provider and use a reputable pharmacy
You may need to temporarily stop using compounded semaglutide to avoid complications
Patel DK, Strong J
